Clinical Trials Logo

Hepatitis b Vaccine clinical trials

View clinical trials related to Hepatitis b Vaccine.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05099757 Not yet recruiting - Hepatitis B Vaccine Clinical Trials

The Immunogenicity and Persistence of Booster Dose With Hepatitis B Vaccine in College Students

Start date: February 20, 2022
Phase: Phase 4
Study type: Interventional

The anti-HBs produced after hepatitis B vaccination will decrease over time. College students are vaccinated with hepatitis B vaccine at birth, and their antibodies may have decreased significantly. In addition, college students are sexually active population, which has a high risk of HBV infection. It is necessary to study the anti-HBs level of college students, and analyze the strengthening immunization for this special group. This study will analyze the immunogenicity, immune persistence, and safety of booster dose of intramuscular 20 µg recombinant hepatitis B vaccines. Different booster vaccination including one-dose (0 month), two-dose (0, 1 months), or three-dose (0, 1, and 6 months) was given according to the antibody production level after booster vaccination among college students.

NCT ID: NCT03962881 Not yet recruiting - Hepatitis B Vaccine Clinical Trials

Research on Optimal Immunization Strategy of Hepatitis B Vaccine in Chronic Kidney Disease Population

Start date: May 25, 2019
Phase: Phase 4
Study type: Interventional

At present, chronic kidney disease population are vaccinated with hepatitis B vaccine according to the standard three-dose schedule immunization program, and the effect of preventing HBV infection is not ideal. This is a randomized, controlled trial. The study will evaluate the immunogenicity and persistence of 20 µg and 60 µg recombinant hepatitis B vaccine with three or four injections at months 0, 1, and 6 or 0, 1, 2, and 6 in chronic kidney disease population.

NCT ID: NCT03962816 Not yet recruiting - Hepatitis B Vaccine Clinical Trials

Immunogenicity and Persistence of Hepatitis B Vaccination in Methadone Maintenance Treatment Patients

Start date: May 26, 2019
Phase: Phase 4
Study type: Interventional

At present, Methadone Maintenance Treatment Patients of Hepatitis B Vaccination in are vaccinated with hepatitis B vaccine according to the standard three-dose schedule immunization program, and the effect of preventing HBV infection is not ideal. This is a randomized, controlled trial. The study will evaluate the immunogenicity and persistence of 20 µg and 60 µg recombinant hepatitis B vaccine with three or four injections at months 0, 1, and 6 or 0, 1,2, and 6 in Methadone Maintenance Treatment Patients

NCT ID: NCT03962803 Not yet recruiting - Hepatitis B Vaccine Clinical Trials

Immunogenicity and Persistence of Hepatitis B Vaccination in HIV-Infected Patients

Start date: June 5, 2019
Phase: Phase 4
Study type: Interventional

At present, HIV-Infected Patients of Hepatitis B Vaccination in are vaccinated with hepatitis B vaccine according to the standard three-dose schedule immunization program, and the effect of preventing HBV infection is not ideal. This is a randomized, controlled trial. The study will evaluate the immunogenicity and persistence of 20 µg and 60 µg recombinant hepatitis B vaccine with three or four injections at months 0, 1, and 6 or 0, 1,2, and 6 in HIV-Infected Patients